• Call +1.858.633.0165 or Fax +1.858.633.0166 or Contact Us

FPL62064 Inhibitor – FPL 62064

For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS5759160

FPL 62064 is a potent dual inhibitor of 5-lipoxygenase (5-LOX) and COX (IC50 of 3.5uM and 3.1uM for RBL-1 cytosolic 5-lipoxygenase and prostaglandin synthetase, respectively). More details

Product Documentation
PDF
Sample Manual Insert View PDF
PDF
Testing Data View PDF
PDF
Certificate of Analysis (COA) View PDF
PDF
QC Report View PDF
PDF
Material Safety Data Sheet View PDF
PDF
Technical Datasheet View PDF
PDF
Protocol View PDF

Product Overview

Online Datasheet in PDF
Product Name
FPL 62064 (FPL62064), Inhibitor
Full Product Name
FPL 62064
Product Gene Name
Form/Format
Solid. Powder
Purity/Purification
99.64%
Preparation and Storage
Store at -20 degree C for 3 years powder
-80 degree C for 2 years in solvent
Molecular Weight
265.31
Solubility
DMSO: 250mg/mL (942.29mM) Need ultrasonic
(<1mg/ml refers to the product slightly soluble or insoluble)
Formula
C16H15N3O
SMILES
COc1ccc(Nc2ccn(n2)-c2ccccc2)cc1
CAS Number
103141-09-9
Target & IC50
RBL-1 cytosolic 5-lipoxygenase: ic50 3.5uM
In Vitro
FPL 62064 inhibited UV irradiation-induced erythema and PGE2 formation in the guinea pig and also oedema formation and eicosanoid production in the mouse ear produced by arachidonic acid. Co-injected with arachidonic acid in rabbit skin, FPL 62064 inhibited oedema and eicosanoid formation.

Structure of FPL62064, inhibitor

FPL62064 Inhibitor – Cat# MBS5759160

Product References and Citations for FPL62064, inhibitor

Blackham A, et al. FPL 62064, a topically active 5-lipoxygenase/cyclooxygenase inhibitor. Agents Actions. 1990 Jun;30(3-4):432-42.
Blackham A, et al. FPL 62064, a topically active 5-lipoxygenase/cyclooxygenase inhibitor. Agents Actions. 1990 Jun;30(3-4):432-42.
Shabaan MA, et al. Synthesis and biological evaluation of pyrazolone analogues as potential anti-inflammatory agents targeting cyclooxygenases and 5-lipoxygenase. Arch Pharm (Weinheim). 2020 Feb 7:e1900308.
Shabaan MA, et al. Synthesis and biological evaluation of pyrazolone analogues as potential anti-inflammatory agents targeting cyclooxygenases and 5-lipoxygenase. Arch Pharm (Weinheim). 2020 Feb 7:e1900308.

Other Notes

Small volumes of FPL62064, inhibitor vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.

Searchable Terms for FPL62064 purchase

MBS5759160 is an inhibitor targeting FPL62064. Also known as FPL 62064.
Request a Quote

Please fill out the form below and our representative will get back to you shortly.

MBS000000
Contact Us

Please fill out the form below and our representative will get back to you shortly.

MBS000000